BNP Paribas Financial Markets’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,850
| Closed | -$374K | – | 4276 |
|
|
2020
Q3 | $374K | Buy |
10,850
+1,172
| +12% | +$25K | ﹤0.01% | 2389 |
|
|
2020
Q2 | $162K | Sell |
9,678
-17,418
| -64% | -$296K | ﹤0.01% | 2578 |
|
|
2020
Q1 | $391K | Buy |
27,096
+20,851
| +334% | +$533K | ﹤0.01% | 2483 |
|
|
2019
Q4 | $209K | Sell |
6,245
-1,708
| -21% | -$47.7K | ﹤0.01% | 2933 |
|
|
2019
Q3 | $167K | Buy |
7,953
+2,099
| +36% | +$42.9K | ﹤0.01% | 2849 |
|
|
2019
Q2 | $122K | Sell |
5,854
-4,203
| -42% | -$86.5K | ﹤0.01% | 2915 |
|
|
2019
Q1 | $225K | Buy |
10,057
+9,052
| +901% | +$213K | ﹤0.01% | 2627 |
|
|
2018
Q4 | $24K | Sell |
1,005
-1,467
| -59% | -$38K | ﹤0.01% | 3038 |
|
|
2018
Q3 | $67.4K | Buy |
2,472
+199
| +9% | +$5.63K | ﹤0.01% | 2933 |
|
|
2018
Q2 | $61.1K | Sell |
2,273
-5,220
| -70% | -$160K | ﹤0.01% | 3030 |
|
|
2018
Q1 | $239K | Buy |
7,493
+214
| +3% | +$7.53K | ﹤0.01% | 2697 |
|
|
2017
Q4 | $275K | Buy |
7,279
+2,881
| +66% | +$93K | ﹤0.01% | 2801 |
|
|
2017
Q3 | $109K | Buy |
4,398
+386
| +10% | +$8.32K | ﹤0.01% | 2732 |
|
|
2017
Q2 | $82.5K | Buy |
4,012
+3,561
| +790% | +$67.9K | ﹤0.01% | 2913 |
|
|
2017
Q1 | $9.8K | Sell |
451
-1,350
| -75% | -$27.7K | ﹤0.01% | 3182 |
|
|
2016
Q4 | $36.8K | Sell |
1,801
-371
| -17% | -$7.58K | ﹤0.01% | 2963 |
|
|
2016
Q3 | $32.6K | Buy |
2,172
+1,070
| +97% | +$14.4K | ﹤0.01% | 2641 |
|
|
2016
Q2 | $11.9K | Buy |
1,102
+1,097
| +21,940% | +$14.9K | ﹤0.01% | 2825 |
|
|
2016
Q1 | $68 | Sell |
5
-2,277
| -100% | -$35.5K | ﹤0.01% | 2633 |
|
|
2015
Q4 | $42.1K | Buy |
2,282
+217
| +11% | +$4.01K | ﹤0.01% | 2929 |
|
|
2015
Q3 | $52.3K | Buy |
+2,065
| New | +$48.3K | ﹤0.01% | 2828 |
|
BNP Paribas Financial Markets's AIMT Position: Q4 2020 in Review
BNP Paribas Financial Markets sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 10,850 shares — an estimated $374K sold.
BNP Paribas Financial Markets first reported a position in AIMT in Q3 2015 and held it in 21 quarters. The position peaked at $391K in Q1 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- BNP Paribas Financial Markets reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 10,850 Aimmune Therapeutics shares in Q4 2020, an estimated $374K.
- BNP Paribas Financial Markets first reported a position in Aimmune Therapeutics in Q3 2015 and held it in 21 quarters.
- BNP Paribas Financial Markets's Aimmune Therapeutics position peaked at $391K in Q1 2020.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.